There has been an increased focus on making healthcare price information more transparent, but with only price information, patients and payers have no way to determine if paying a higher price is warranted.
There has been an increased focus on making healthcare price information more transparent, but with only price information, patients and payers have no way to determine if paying a higher price is warranted.
In an April 2016 Data Brief, “The Price-Quality Paradox in Health Care,” Eric Barrette and Kevin Kennedy of the Health Care Cost Institute (HCCI) concluded that the quality of healthcare services is largely unrelated to healthcare price.
The Data Brief found that patients and payers are limited in how they can use cost information without knowing what to expect for a given price. Price alone may not be sufficient for identifying quality, Barrette and Kennedy concluded. In some cases it appears that higher prices are actually associated with lower quality.
The HCCI Data Brief calculated quality of care measures with the same claims data used to estimate the average prices of common healthcare services that are publicly available. These measures are reported at the local, state, and national levels. The data set included deidentified HIPPA-compliant health insurance claims from multiple national health insurers, representing over 50 million covered lives. Membership and claims data included details such as zip codes, diagnostic codes, procedure codes, actual amounts paid by the insurer as well as copayments paid by the insured. Individual and employer-sponsored insurance claims were included in the analyses.
Quality and price of 5 measures are discussed in the brief: one related to asthma (asthma evaluation); 2 related to diabetes (diabetes evaluation and hemoglobin A1C test); and 2 related to hypertension (hypertension evaluation and creatinine test). The 5 state-level quality measures and their comparable price estimates were obtainable for 42 states and the District of Columbia.
The authors found the following:
“Although stakeholders need more information about the costs of health care services, they are limited in how they can use that information without knowing what to expect for a given price,” the authors wrote. “If policy makers and healthcare industry leaders expect transparency efforts to have real impacts on the healthcare system, making quality information more accessible and useable by stakeholders is also necessary.”
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
What We’re Reading: FDA Approves UTI Antibiotic; Ozempic, Wegovy Price Investigation; US Births Fall
April 25th 2024The FDA recently approved an antibiotic for the treatment of urinary tract infections (UTIs) in women; a Senate committee recently launched an investigation into the prices of Novo Nordisk’s diabetes and weight loss drugs; US births fell last year, resuming a national slide after a previous increase during the pandemic.
Read More
HOPE-CAT Can Identify Maternal Cardiovascular Risk 2 Months Earlier Than Doctors, Study Says
April 25th 2024In a retrospective study, the machine learning tool was able to screen for potential risks of cardiovascular disease nearly 60 days before the patient's medical record showed any signs of a related condition or before they were officially diagnosed or treated for it.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
What We’re Reading: FDA Approves UTI Antibiotic; Ozempic, Wegovy Price Investigation; US Births Fall
April 25th 2024The FDA recently approved an antibiotic for the treatment of urinary tract infections (UTIs) in women; a Senate committee recently launched an investigation into the prices of Novo Nordisk’s diabetes and weight loss drugs; US births fell last year, resuming a national slide after a previous increase during the pandemic.
Read More
HOPE-CAT Can Identify Maternal Cardiovascular Risk 2 Months Earlier Than Doctors, Study Says
April 25th 2024In a retrospective study, the machine learning tool was able to screen for potential risks of cardiovascular disease nearly 60 days before the patient's medical record showed any signs of a related condition or before they were officially diagnosed or treated for it.
Read More
2 Commerce Drive
Cranbury, NJ 08512